Glesatinib
Product Specifications
CAS Number
936694-12-1
Synonyms
MGCD265
Target
C-Met
Applications
Protein Tyrosine Kinase
Molecular Formula
C31H27F2N5O3S2
Additionnal Information
Glesatinib (MGCD265) is an orally bioavailable potent dual inhibitor of c-MET and SMO. Glesatinib counteracts P-glycoprotein (P-gp) mediated multidrug resistance (MDR) in non-small cell lung cancer (NSCLC) .
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
